Qualified Digital (QD), a leading full-service digital business and experience agency, has announced its acquisition of Xpediant Digital, a premier provider of content supply chain automations for Pharma and Life Sciences as a services and product partner. Through its innovative and integrated product, built natively into Adobe Experience Manager and Veeva, Xpediant and its solutions transform the regulatory process for its customers creating an incredible return on time and costs. With over two decades of delivering high quality services and innovative products to solve some of the greatest challenges in highly regulated industries such as Pharma and Medtech, Xpediant expands Qualified Digital’s focus on quality and high business impact within the Healthcare industry. With Qualified Digital’s strategically led practice spanning the entire Adobe Experience Cloud, notably its rapidly expanding Adobe AEP and Workfront practices, the newly combined capabilities, and powerful talent, stand to truly disrupt the pharmaceutical and life sciences industry go-to-market process.
Said Jaqueline Saleem, CEO, Qualified Digital: “We are beyond thrilled to welcome Xpediant to the QD family, expanding our collective capabilities to our existing and future customers. We are excited to hit the ground running, transforming content operations including MLR (Medical Legal Regulatory), while elevating digital experiences through consumer-led experience design and ecosystem orchestration. As the experience economy continues to realize the importance of end-to-end service providers who not only understand each standalone solution, but can execute on the vision and promise of orchestrating those connections to multiply the value they bring, our ethos only becomes stronger and ever more essential. The ability to automate and deliver truly multi-channel experiences from IVA, banner ads, email, SMS, web experiences and more has actually been made accessible to these brands in ways that have previously been arduous to attain. This acquisition doubles down on QD’s commitment to accomplish ROI for our customers from both cost reduction and, even more so, revenue generating returns.”
Added Qusai Mahesri, CEO, Xpediant Digital, “With content creation demands growing exponentially, Pharma organizations need smarter, more efficient solutions. Joining the Qualified Digital family allows us to deliver an integrated approach that optimizes the entire content lifecycle from strategy and development to compliance and deployment. Customers have realized both months of time and millions in cost savings within a year of adopting Xpediant’s XpConnect® platform and elite services.”
Xpediant’s clients include life science powerhouses Novo Nordisk, Fresenius, Bristol Myers Squibb, AstraZeneca and Zimmer Biomet.
QD serves clients in various industries, including CommonSpirit Health, Cigna, Mercy Health, CVS Health, Kaiser Permanente, Hitachi Vantara, and Rubrik.
The acquisition of Xpediant represents QD’s first major expansion since partnering with Stella Point Capital, who invested in QD in 2024 to help scale its long term vision for expansion and growth.
For more such updates, follow us on Google News Martech News